Invivyd, Inc. (IVVD) vs Palisade Bio, Inc. (PALI)
Invivyd, Inc. and Palisade Bio, Inc. are both Biotechnology companies. Invivyd, Inc. and Palisade Bio, Inc. are of similar size ($274.1M and $273.6M). Invivyd, Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 2.2×. Palisade Bio, Inc. grew revenue faster over the last twelve months: 5,492.6% against 26.3%. Invivyd, Inc. has the higher net margin (−183.9% vs −4,230.6%) and the lower return on invested capital (−334.9% vs 0.00%). Across the 16 metrics below, Palisade Bio, Inc. leads on 9 and Invivyd, Inc. on 7.
Valuation
Profitability
| Metric | IVVD | PALI | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.23% | 95.63% | 65.16% |
| Operating margin | (192.81%) | (4,681.99%) | 0.00% |
| Net margin | (183.90%) | (4,230.60%) | 0.00% |
| Free cash flow margin | (187.88%) | (2,409.27%) | 0.00% |
| Return on equity | (95.89%) | (51.37%) | (57.72%) |
| Return on assets | (69.69%) | (47.68%) | (49.22%) |
| Return on invested capital | (334.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack